Literature DB >> 1394872

Adenosine A1 receptor activation attenuates cardiac injury produced by hydrogen peroxide.

M Karmazyn1, M A Cook.   

Abstract

Adenosine has been shown to protect the ischemic and reperfused myocardium. To examine whether the protective effect of the nucleoside is mediated by modulation of oxidative stress, isolated rat hearts were perfused for 30 minutes with 100 microM H2O2 or an exogenous free radical-generating system consisting of purine (3.06 mM) and xanthine oxidase (10 units/l) in the presence or absence of drugs acting on adenosine A1 or A2 receptors. H2O2 alone produced a greater than 90% loss in contractility concomitant with a threefold elevation in resting tension, although these effects occurred in the absence of ultrastructural damage. Two A1 receptor agonists N6-cyclopentyladenosine (CPA, 1 microM) and R(-)-N6-(2-phenylisopropyl)adenosine (R-PIA, 1 microM) significantly attenuated the cardiodepressant effects of H2O2 and depressed the elevation in resting tension; however, only the effect of CPA was found to be significant with regard to the latter parameter. A similar concentration of S(+)-N6-(2-phenylisopropyl)adenosine (S-PIA), a markedly less potent A1 receptor agonist, was found to be without beneficial effect. However, a significant protective effect against both the reduction in contractility and the elevation in resting tension was seen with a 10-fold elevation in the concentration of S-PIA (10 microM). The protective effects on functional parameters were associated with preservation of high-energy phosphate and adenine nucleotide contents after 30 minutes of H2O2 treatment. The salutary effects of all drugs were reversed in the presence of the A1 receptor antagonist 1,3-dipropyl-8-cyclopentylxanthine (0.5 microM). An A2 receptor agonist 2-[p-(carboxyethyl)phenethylamino]-5'-N-ethylcarboxamidoadenosine, termed CGS 21680 (1 microM), failed to alter the cardiac response to H2O2 with regard to all parameters studied. Neither a 50% reduction in external CaCl2 concentration nor treatment with 10 microM DL-propranolol exerted salutary effects against H2O2-induced dysfunction. None of the A1 receptor agonists modulated the response to purine plus xanthine oxidase. Our results demonstrate a selective protective effect of adenosine A1 receptor activation against the cardiac toxicity of H2O2 and provide, at least in part, a basis for the cardioprotective actions of adenosine and its analogues.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1394872     DOI: 10.1161/01.res.71.5.1101

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  6 in total

1.  Prostaglandins attenuate cardiac contractile dysfunction produced by free radical generation but not by hydrogen peroxide.

Authors:  K M Zimmer; M Karmazyn
Journal:  Mol Cell Biochem       Date:  1997-11       Impact factor: 3.396

2.  Oxidant stress and damage in post-ischemic mouse hearts: effects of adenosine.

Authors:  Benjamin Hack; Paul K Witting; Benjamin S Rayner; Roland Stocker; John P Headrick
Journal:  Mol Cell Biochem       Date:  2006-05-23       Impact factor: 3.396

Review 3.  Mechanisms of induction of adenosine receptor genes and its functional significance.

Authors:  Cynthia St Hilaire; Shannon H Carroll; Hongjie Chen; Katya Ravid
Journal:  J Cell Physiol       Date:  2009-01       Impact factor: 6.384

4.  Adenosine-sensitive alpha 1-adrenoceptor effects on reperfused ischaemic hearts: comparison with phorbol ester.

Authors:  N Khandoudi; M P Moffat; M Karmazyn
Journal:  Br J Pharmacol       Date:  1994-08       Impact factor: 8.739

5.  Endogenous adenosine selectively modulates oxidant stress via the A1 receptor in ischemic hearts.

Authors:  Melissa E Reichelt; Anu Shanu; Laura Willems; Paul K Witting; Natasha A Ellis; Michael R Blackburn; John P Headrick
Journal:  Antioxid Redox Signal       Date:  2009-11       Impact factor: 8.401

Review 6.  Bone Marrow and Adipose Tissue Adenosine Receptors Effect on Osteogenesis and Adipogenesis.

Authors:  Anna Eisenstein; Shlok V Chitalia; Katya Ravid
Journal:  Int J Mol Sci       Date:  2020-10-10       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.